Literature DB >> 15833921

New restrictions on celecoxib (Celebrex) use and the withdrawal of valdecoxib (Bextra).

Jill Cotter1, Eric Wooltorton.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15833921      PMCID: PMC557099          DOI: 10.1503/cmaj.050456

Source DB:  PubMed          Journal:  CMAJ        ISSN: 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  2 in total

1.  Cardiovascular risk associated with celecoxib in a clinical trial for colorectal adenoma prevention.

Authors:  Scott D Solomon; John J V McMurray; Marc A Pfeffer; Janet Wittes; Robert Fowler; Peter Finn; William F Anderson; Ann Zauber; Ernest Hawk; Monica Bertagnolli
Journal:  N Engl J Med       Date:  2005-02-15       Impact factor: 91.245

2.  Complications of the COX-2 inhibitors parecoxib and valdecoxib after cardiac surgery.

Authors:  Nancy A Nussmeier; Andrew A Whelton; Mark T Brown; Richard M Langford; Andreas Hoeft; Joel L Parlow; Steven W Boyce; Kenneth M Verburg
Journal:  N Engl J Med       Date:  2005-02-15       Impact factor: 91.245

  2 in total
  6 in total

1.  Coxibs and cardiovascular risk.

Authors:  Michal R Pijak; Igor Huzicka; Frantisek Gazdik
Journal:  CMAJ       Date:  2005-10-11       Impact factor: 8.262

2.  Coxibs and cardiovascular risk.

Authors:  Michael J Allen; Pamela McLean-Veysey; Isobel Fleming
Journal:  CMAJ       Date:  2005-10-11       Impact factor: 8.262

3.  Coxibs and cardiovascular risk.

Authors:  Syed A H Zaidi
Journal:  CMAJ       Date:  2005-10-11       Impact factor: 8.262

Review 4.  The need for "gentle medicine" in a post Covid-19 world.

Authors:  Gabriel Andrade; Maria Campo Redondo
Journal:  Med Health Care Philos       Date:  2021-08-20

Review 5.  Pharmacovigilance in perspective: drug withdrawals, data mining and policy implications.

Authors:  Muaed Alomar; Subish Palaian; Moawia M Al-Tabakha
Journal:  F1000Res       Date:  2019-12-16

6.  Twelve years' experience with direct-to-consumer advertising of prescription drugs in Canada: a cautionary tale.

Authors:  Barbara Mintzes; Steve Morgan; James M Wright
Journal:  PLoS One       Date:  2009-05-27       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.